{
    "organizations": [],
    "uuid": "07c48ce274cb79fb2b29e2bb37684ccd0090f50d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-philab-holdings-clarifies-on-news/brief-philab-holdings-clarifies-on-news-articles-idUSL8N1PV1R5",
    "ord_in_thread": 0,
    "title": "BRIEF-Philab Holdings Clarifies On News Articles",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 5 (Reuters) - Philab Holdings Corp:\n* CONFIRMS ARTICLES ENTITLED “PHILAB TO RAISE UP TO $150 MILLION” AND “PHILAB INVESTS IN US-BASED GENOME SEQUENCING COMPANY”\n* ON FEB 2, SIGNED TERM SHEET WITH VERITAS GENETICS INTERNATIONAL; YAMAKAZI FINANCIAL INFUSED 500 MILLION PESOS TO DNA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-05T17:53:00.000+02:00",
    "crawled": "2018-02-07T00:20:06.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "philab",
        "holding",
        "corp",
        "confirms",
        "article",
        "entitled",
        "philab",
        "raise",
        "million",
        "philab",
        "invests",
        "genome",
        "sequencing",
        "company",
        "feb",
        "signed",
        "term",
        "sheet",
        "veritas",
        "genetics",
        "international",
        "yamakazi",
        "financial",
        "infused",
        "million",
        "peso",
        "dna",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}